Stock-Based Compensation - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
	Jan. 31, 2022	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2018	Dec. 31, 2021
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Employees Including Executive Officers Earning Contribution				15.00%
Option Granted				1,665,782
Share-Based Payment Arrangement, Expense		$ 1,772	$ 1,050	$ 3,313	$ 1,347
Percentage of fair market value, common stock		85.00%		85.00%
Number of shares, Granted						21,750
Restricted Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, award vesting rights, percentage				25.00%
Share-Based Payment Arrangement, Expense				$ 200
Common stock reserved for future issuance							21,750
Number of shares, Granted				0
Stock Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, award vesting rights, percentage				25.00%
Share-based payment award, option vesting period				4 years
Options grants in period, weighted average grant date fair value				$ 5.32
Unrecognized compensation cost		$ 17,800		$ 17,800
Unrecognized compensation, weighted average amortization period				2 years 11 months 19 days
Unvested Restricted Stock Awards [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Unrecognized compensation cost		$ 1,860		$ 1,860
Unrecognized compensation, weighted average amortization period				2 years 8 months 15 days
Performance Shares [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Option Granted	45,000
2019 Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, description				Under the terms of the 2019 Plan, options are granted at an exercise price no less than fair value of the Company’s common stock on the grant date, except in certain cases related to employees outside of the U.S. However, for any employee who is a 10% or greater stockholder, options are granted at an exercise price no less than 110% of the fair value of the Company’s common stock on the grant date. Option awards granted typically have 10-year terms measured from the option grant date. However, if any employee is a 10% or greater stockholder, the awards have 5-year terms measured from the option grant date. While no shares are available for future issuance under the 2019 Plan, it continues to govern outstanding equity awards granted thereunder.
Share based payment award, purchase price of common stock, percent				110.00%
Share-based payment award, expiration period				10 years
2019 Equity Incentive Plan | Employee is 10% or Greater Stockholder [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, expiration period				5 years
2021 Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, expiration period				10 years
Share-based payment award, number of shares authorized		3,887,174		3,887,174
Number of Shares of Common Stock Outstanding Percentage				5.00%
ESPP
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, description				The ESPP allows employees, including executive officers, to contribute up to 15% of their earnings, subject to certain limitations, for the purchase of the Company's common stock at a price per share equal to the lower of (a) 85% of the fair market value of a share of common stock on the first day of the offering period, or (b) 85% of the fair market value of a share of common stock on the last day of the offering period. As of June 30, 2022, there were 521,555 shares of common stock reserved for future issuance under the ESPP plan. The number of shares of common stock reserved for issuance under the ESPP will automatically increase on January 1 of each calendar year, beginning on January 1, 2022 and continuing through and including January 1, 2031, by the lesser of (1) 1% of the total number of shares of the Company's common stock outstanding on December 31 of the preceding calendar year or (2) a number of shares determined by the Company's board of directors. Shares subject to purchase rights granted under the ESPP that terminate without having been exercised in full will not reduce the number of shares available for issuance under the ESPP.As of June 30, 2022, no shares have been granted or purchased under the ESPP.
Common stock reserved for future issuance		521,555		521,555
Number of Shares of Common Stock Outstanding Percentage				1.00%
Number of shares, Granted				0